Regulatory Alerts2020-01-01 | Bulletin 2020-12Bulletin 2020-12: Implementation of 60-Day Advance Notice for Specified Prescription Drug Price Increases Under 2019 House Bill 2658
The Oregon Department of Consumer and Business Services issued Bulletin 2020-12 to implement 2019 House Bill 2658, which mandates that prescription drug manufacturers provide a 60-day advance report for planned cumulative price increases meeting statutory thresholds. Following two public comment periods, the department incorporated revisions addressing industry concerns by establishing a pre-disclosure trade secret review process, clarifying that price decreases do not trigger reporting requirements, and specifying a rolling 12-month lookback period for threshold calculations. The agency ultimately adopted the bulletin with these modifications while maintaining the statutory mandate for public disclosure of reports and declining to alter the legislative reporting thresholds or constitutional provisions.